Format

Send to

Choose Destination
PLoS One. 2015 Jun 15;10(6):e0129776. doi: 10.1371/journal.pone.0129776. eCollection 2015.

Modulation of PICALM Levels Perturbs Cellular Cholesterol Homeostasis.

Author information

1
Department of Pharmacology & Cancer Biology, Duke University, Durham, North Carolina, United States of America.
2
Department of Microbiology, Immunology and Molecular Genetics, Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, United States of America.
3
Department of Pediatrics, Division of Pediatric Hematology-Oncology, Duke University, Durham, North Carolina, United States of America.
4
Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, United States of America; Center for Genomic and Computational Biology, Duke University, Durham, North Carolina, United States of America.
5
Department of Radiology, Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
6
Department of Pharmacology & Cancer Biology, Duke University, Durham, North Carolina, United States of America; Department of Pediatrics, Division of Pediatric Hematology-Oncology, Duke University, Durham, North Carolina, United States of America.

Abstract

PICALM (Phosphatidyl Inositol Clathrin Assembly Lymphoid Myeloid protein) is a ubiquitously expressed protein that plays a role in clathrin-mediated endocytosis. PICALM also affects the internalization and trafficking of SNAREs and modulates macroautophagy. Chromosomal translocations that result in the fusion of PICALM to heterologous proteins cause leukemias, and genome-wide association studies have linked PICALM Single Nucleotide Polymorphisms (SNPs) to Alzheimer's disease. To obtain insight into the biological role of PICALM, we performed gene expression studies of PICALM-deficient and PICALM-expressing cells. Pathway analysis demonstrated that PICALM expression influences the expression of genes that encode proteins involved in cholesterol biosynthesis and lipoprotein uptake. Gas Chromatography-Mass Spectrometry (GC-MS) studies indicated that loss of PICALM increases cellular cholesterol pool size. Isotopic labeling studies revealed that loss of PICALM alters increased net scavenging of cholesterol. Flow cytometry analyses confirmed that internalization of the LDL receptor is enhanced in PICALM-deficient cells as a result of higher levels of LDLR expression. These findings suggest that PICALM is required for cellular cholesterol homeostasis and point to a novel mechanism by which PICALM alterations may contribute to disease.

PMID:
26075887
PMCID:
PMC4467867
DOI:
10.1371/journal.pone.0129776
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center